mhurhangee/ep-ind-claims huggingface dataset:
A resistance spot welding method for joining a sheet set including a plurality of lapped steel sheets (1, 2), the method comprising: holding the sheet set between a pair of electrodes (3, 4); and energizing the sheet set under application of electrode force to thereby join the steel sheets (1, 2) together, wherein at least one of the plurality of lapped steel sheets (1, 2) is a surface-treated steel sheet including a Zn-based coating layer on a surface thereof, characterised in that the energizing comprises a primary energizing step of performing energization to form a nugget portion, a non-energizing step in which, after the primary energizing step, the energization is suspended for an energization suspension time Tc, a secondary energizing step of, after the non-energizing step, performing energization for reheating while the nugget portion is prevented from growing, and wherein, during the energizing, the relations of the following formula are satisfied: 22 + A ⋅ B / 100 < Ip / Im < C when 0 < A < 3, 17 + A ⋅ B / 80 < Ip / Im < C when 3 ≤ A < 7, 11 + A ⋅ B / 60 < Ip / Im < C when 7 ≤ A < 15, and where A is an electrode misalignment angle (degrees) of the electrodes (3, 4), Im is a current value (kA) in the primary energizing step, Ip is a current value (kA) in the secondary energizing step, B is a variable defined as 1 + 0.1·Tc, and C is a variable defined as 1 + 0.2·Tc, and wherein when 3 ≤ A < 7 and when 7 ≤ A < 15, it is necessary to perform the secondary energizing step using a higher current than the primary energizing step. A resistance spot welding method for joining a sheet set including a plurality of lapped steel sheets (1, 2), the method comprising: holding the sheet set between a pair of electrodes (3, 4); and energizing the sheet set under application of electrode force to thereby join the steel sheets (1, 2) together, wherein at least one of the plurality of lapped steel sheets (1, 2) is a surface-treated steel sheet including a Zn-based coating layer on a surface thereof, characterised in that the energizing comprises a primary energizing step of performing energization to form a nugget portion, a non-energizing step in which, after the primary energizing step, the energization is suspended for an energization suspension time Tc, a secondary energizing step of, after the non-energizing step, performing energization for reheating while the nugget portion is prevented from growing, and wherein, during the energizing, the relations of the following formula are satisfied: 22 + A ⋅ B / 100 < Ip / Im < C when 0 < A < 3, 17 + A ⋅ B / 80 < Ip / Im < C when 3 ≤ A < 7, 11 + A ⋅ B / 60 < Ip / Im < C when 7 ≤ A < 15, and where A is an electrode misalignment angle (degrees) of the electrodes (3, 4), Im is a current value (kA) in the primary energizing step, Ip is a current value (kA) in the secondary energizing step, B is a variable defined as 1 + 0.1·Tc, and C is a variable defined as 1 + 0.2·Tc, and wherein when 3 ≤ A < 7 and when 7 ≤ A < 15, it is necessary to perform the secondary energizing step using a higher current than the primary energizing step.
A composition comprising: a therapeutically effective amount of (i) an isolated LukE polypeptide that is 200-300 amino acids in length and comprises the amino acid sequence of amino acid residues 48-291 of SEQ ID NO:11, (ii) an isolated LukD polypeptide that is 250-300 amino acids in length and comprises the amino acid sequence of amino acid residues 46-307 of SEQ ID NO:22, or (iii) a combination thereof, and a pharmaceutically acceptable carrier. a therapeutically effective amount of (i) an isolated LukE polypeptide that is 200-300 amino acids in length and comprises the amino acid sequence of amino acid residues 48-291 of SEQ ID NO:11, (ii) an isolated LukD polypeptide that is 250-300 amino acids in length and comprises the amino acid sequence of amino acid residues 46-307 of SEQ ID NO:22, or (iii) a combination thereof, and a pharmaceutically acceptable carrier.
A method for operating a blast furnace, comprising charging ore and coke including a carbon iron composite and conventional coke into the blast furnace,, characterized in that the carbon iron composite has a particle size of 15 mm to 40 mm, the percentage of the carbon iron composite used is 30% to 50% by mass of the coke, and the carbon iron composite has an iron content of 30% to 40% by mass.
A medical imaging apparatus comprising: a processor configured to generate volume data of an object containing a target site to be inspected; determine a reference section from among a plurality of 2D sections of the object based on a first user input, wherein the plurality of 2D sections are generated by slicing the volume data of the object in a plurality of predetermined directions; generate a plurality of sample sections parallel to the reference section within the volume data of the object; detect the target site from each of the plurality of sample sections and calculate a center of each target site; generate marker data, wherein the marker data are volume data of each volume marker located at a position corresponding to the center of each target site; generate synthesized data of the reference section by synthesizing the volume data of the object and the marker data; generate a plurality of sectional images by slicing the synthesized data of the object in the plurality of predetermined directions wherein the processor generates a plurality of projection images through rendering of the synthesized data from a plurality of viewpoints and generates a stereo projection image by composing the projection images; and a display configured to display the plurality of sectional images and the stereo projection image including the volume marker. a processor configured to generate volume data of an object containing a target site to be inspected; determine a reference section from among a plurality of 2D sections of the object based on a first user input, wherein the plurality of 2D sections are generated by slicing the volume data of the object in a plurality of predetermined directions; generate a plurality of sample sections parallel to the reference section within the volume data of the object; detect the target site from each of the plurality of sample sections and calculate a center of each target site; generate marker data, wherein the marker data are volume data of each volume marker located at a position corresponding to the center of each target site; generate synthesized data of the reference section by synthesizing the volume data of the object and the marker data; generate a plurality of sectional images by slicing the synthesized data of the object in the plurality of predetermined directions wherein the processor generates a plurality of projection images through rendering of the synthesized data from a plurality of viewpoints and generates a stereo projection image by composing the projection images; and a display configured to display the plurality of sectional images and the stereo projection image including the volume marker.
A method, comprising: detecting, by a computer server, an appliance in communication with the computer server via a computer network; receiving, by the computer server, information indicating capabilities of the appliance; receiving audio input from a user converted by an electroacoustic transducer into an audio signal; and determining control settings controlling the capabilities of the appliance, based on the audio signal, wherein the control settings comprise at least one of: a schedule corresponding to one or more times at which the appliance is to power on or off; a setting deferring configuration of the appliance to a later time; or one or more operations to be performed by the appliance when it is powered on. detecting, by a computer server, an appliance in communication with the computer server via a computer network; receiving, by the computer server, information indicating capabilities of the appliance; receiving audio input from a user converted by an electroacoustic transducer into an audio signal; and determining control settings controlling the capabilities of the appliance, based on the audio signal, wherein the control settings comprise at least one of: a schedule corresponding to one or more times at which the appliance is to power on or off; a setting deferring configuration of the appliance to a later time; or one or more operations to be performed by the appliance when it is powered on. a schedule corresponding to one or more times at which the appliance is to power on or off; a setting deferring configuration of the appliance to a later time; or one or more operations to be performed by the appliance when it is powered on.
A near field magnetic resonance (NFMR) power supply arranged to use a resonance channel to transfer energy to resonance circuits within a near field distance, said distance defining an outermost range of the NFMR power supply, comprising: a high frequency power source for providing a high frequency, orthogonal in-band power; and a base plate that provides high frequency power coupled to the HF power source; characterised in that the power supply comprises at least two "D" shaped resonators arranged to receive HF power from the base plate, wherein the at least two D shaped resonators are driven 180 degrees out of phase with each other, wherein the magnetic fields produced by the at least two D shaped resonators are arranged to provide a symmetric magnetic field at a resonant frequency. a high frequency power source for providing a high frequency, orthogonal in-band power; and a base plate that provides high frequency power coupled to the HF power source; characterised in that the power supply comprises at least two "D" shaped resonators arranged to receive HF power from the base plate, wherein the at least two D shaped resonators are driven 180 degrees out of phase with each other, wherein the magnetic fields produced by the at least two D shaped resonators are arranged to provide a symmetric magnetic field at a resonant frequency.
A method of preparing a tumor inhibiting conditioned heterologous acellular collagenous material substrate comprising anti-tumor, anti-cancer or combination of anti-tumor and anti-cancer biomolecules comprising a combination of 2 or more of: fibrinogen, bFGF, PDGF, TNFα, endothelins, plasmin or uPA, and wherein said conditioned heterologous acellular collagenous material substrate is substantially devoid of cells, wherein said method comprises: - culturing melanoma mammalian cells on a heterologous acellular collagenous material substrate suitable for the culture of said cells, for a period of time and under conditions suitable for growth of said cells on said substrate so as to provide a conditioned substrate; and - processing said conditioned heterologous collagenous substrate to remove cellular components from said conditioned heterologous collagenous substrate. - culturing melanoma mammalian cells on a heterologous acellular collagenous material substrate suitable for the culture of said cells, for a period of time and under conditions suitable for growth of said cells on said substrate so as to provide a conditioned substrate; and - processing said conditioned heterologous collagenous substrate to remove cellular components from said conditioned heterologous collagenous substrate.
Electrode (1, 11) comprising: at least a first glass body (2, 12, 22), preferably cylindrical, in which at least one chamber is formed, at least a first electrolyte, which is arranged in the first chamber, at least one element (4, 14, 24) forming a first potential, said element being arranged in the chamber, and forming a first potential when coming into contact with the first electrolyte, at least a first sealing element (5, 15, 25), which is axially fixed in the first chamber including the first electrolyte and the element forming the first potential, and which seals said chamber in a tight manner, characterized in that the first sealing element (5, 15, 25) is conductive, the sealing element (5, 15, 25) comprises a conductive sealing body that has an elastomer, the element (4, 14, 24) forming the first potential establishes a conductive contact with the first sealing element (5, 15, 25), and the electrode (1, 11) further comprises at least a first electrical conductor (7, 17, 27), which establishes an electrical contact with the first sealing element (5, 15, 25) on the side of the first sealing element (5, 15, 25) facing away from the first electrolyte. at least a first glass body (2, 12, 22), preferably cylindrical, in which at least one chamber is formed, at least a first electrolyte, which is arranged in the first chamber, at least one element (4, 14, 24) forming a first potential, said element being arranged in the chamber, and forming a first potential when coming into contact with the first electrolyte, at least a first sealing element (5, 15, 25), which is axially fixed in the first chamber including the first electrolyte and the element forming the first potential, and which seals said chamber in a tight manner,
A fine particle, comprising a complex consisting of a polycarboxylic acid derivative and a drug, wherein the polycarboxylic acid derivative is a compound produced by condensing a polycarboxylic acid and a propargyl amino acid represented by the following formula: wherein R is a hydrogen atom or a C 1-8 hydrocarbon group, a plurality of hydrogen atom in the hydrocarbon group may be substituted by a nitrogen atom, an oxygen atom or a sulfur atom, n is an integer of 1 or more and 3 or less, and wherein the fine particle is water-dispersible. comprising a complex consisting of a polycarboxylic acid derivative and a drug, wherein the polycarboxylic acid derivative is a compound produced by condensing a polycarboxylic acid and a propargyl amino acid represented by the following formula: R is a hydrogen atom or a C 1-8 hydrocarbon group, a plurality of hydrogen atom in the hydrocarbon group may be substituted by a nitrogen atom, an oxygen atom or a sulfur atom, n is an integer of 1 or more and 3 or less, and wherein the fine particle is water-dispersible.
A blind slat threading device comprising a base on which a mounting plate is arranged and on which two supporting stands are arranged opposite each other, between which a space is arranged for vertical movement of a ladder with vertical ladder cords and pairs of transverse ladder strings arranged between them with a slit between them, whereby each supporting stand is provided with two pneumatic actuator modules, each stand bearing one assembly consisting of a front jaw and a rear jaw, whereas the front jaws are provided with an upper half-tooth at the top and a lower half-tooth at the bottom and two middle teeth arranged between them, wherein on the front jaws carriers of guiding grooves with a needle for guiding the slat are arranged, wherein the front abutting portion of the carrier is an integral part of the front jaws and on the rear linearly movable working portion of the guiding grooves are arranged, wherein the size of the guiding grooves corresponds to the size of the gap between the middle teeth, the rear jaws are provided with an upper half-tooth at the top and a lower half-tooth at the bottom, whereas between the upper half-tooth and the upper middle tooth and the lower half-tooth and the lower middle tooth of the front jaws gaps are arranged, against which dimensionally corresponding upper half-tooth and lower half-tooth on the rear jaws are arranged, whereas the jaws (6, 6') are pivotally connected to the upper cover plate of the supporting stand via an arm and a pin arranged thereon, and at the same time via a holder which is part of the pneumatic actuator module with a supporting fork, wherein holes are created in the mounting plate, whereas in the holes two positioning gears are rotatably arranged, which engage with gear segments which are fixed via a support plate to the lower part of the rear jaw.
An isolated polypeptide comprising an E. coli heat-labile enterotoxin subunit A, the E. coli heat-labile enterotoxin subunit A having an amino acid sequence selected from a group consisting of SEQ ID NOs: 2, 4, 8, and 10, wherein an E. coli heat-labile enterotoxin containing the subunit A having an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 8 and 10 has a reduced toxicity when compared to a wild-type E. coli heat-labile enterotoxin containing SEQ ID NO:5.
An additive for a non-aqueous electrolyte solution represented by formula: wherein in formula, Z 1 to Z 4 are each independently a fluorine atom or an organic group selected from the group consisting of linear or branched alkyl groups having 1 to 10 carbon atoms, linear or branched alkoxy groups having 1 to 10 carbon atoms, linear or branched alkenyl groups having 2 to 10 carbon atoms, linear or branched alkenyloxy groups having 2 to 10 carbon atoms, linear or branched alkynyl groups having 2 to 10 carbon atoms, linear or branched alkynyloxy groups having 2 to 10 carbon atoms, cycloalkyl groups having 3 to 10 carbon atoms, cycloalkoxy groups having 3 to 10 carbon atoms, cycloalkenyl groups having 3 to 10 carbon atoms, cycloalkenyloxy groups having 3 to 10 carbon atoms, aryl groups having 6 to 10 carbon atoms, and aryloxy groups having 6 to 10 carbon atoms, where the organic group optionally contains a fluorine atom, an oxygen atom, or an unsaturated bond, and at least one of Z 1 to Z 4 is a fluorine atom; M p + is a proton, a metal cation, or an onium cation; and p is a cation valence. wherein in formula, Z 1 to Z 4 are each independently a fluorine atom or an organic group selected from the group consisting of linear or branched alkyl groups having 1 to 10 carbon atoms, linear or branched alkoxy groups having 1 to 10 carbon atoms, linear or branched alkenyl groups having 2 to 10 carbon atoms, linear or branched alkenyloxy groups having 2 to 10 carbon atoms, linear or branched alkynyl groups having 2 to 10 carbon atoms, linear or branched alkynyloxy groups having 2 to 10 carbon atoms, cycloalkyl groups having 3 to 10 carbon atoms, cycloalkoxy groups having 3 to 10 carbon atoms, cycloalkenyl groups having 3 to 10 carbon atoms, cycloalkenyloxy groups having 3 to 10 carbon atoms, aryl groups having 6 to 10 carbon atoms, and aryloxy groups having 6 to 10 carbon atoms, where the organic group optionally contains a fluorine atom, an oxygen atom, or an unsaturated bond, and at least one of Z 1 to Z 4 is a fluorine atom; M p + is a proton, a metal cation, or an onium cation; and p is a cation valence.
A compound having the formula Ir(L A) n (L B) 3-n, having the structure: Formula I; wherein R 1 and R 5 each independently represent mono, di, tri, or tetra-substitution, or no substitution; wherein R 2 represents up to tri-substitution, or no substitution; wherein R 4 represents mono, or di-substitution, or no substitution; wherein X 1, X 2, X 3, and X 4 are each independently C or N; wherein any adjacent substituents of R 1, R 2, R 3, R 4, and R 5 are optionally linked together to form a ring; wherein each R 1, R 2, R 3, R 4, and R 5 is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein n is either 1 or 2; characterised in that at least one of X 1, X 2, X 3, and X 4 is N. wherein R 1 and R 5 each independently represent mono, di, tri, or tetra-substitution, or no substitution; wherein R 2 represents up to tri-substitution, or no substitution; wherein R 4 represents mono, or di-substitution, or no substitution; wherein X 1, X 2, X 3, and X 4 are each independently C or N; wherein any adjacent substituents of R 1, R 2, R 3, R 4, and R 5 are optionally linked together to form a ring; wherein each R 1, R 2, R 3, R 4, and R 5 is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein n is either 1 or 2; characterised in that at least one of X 1, X 2, X 3, and X 4 is N.
Photolabile hydrazine linker having the formula I: wherein R* is a bond or OR', wherein R' is hydrogen, C 1-12 alkyl, substituted C 1-10 alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl or -(CH 2 -CH 2 -O)- m; R is hydrogen or a protection group; m is an integer from 1-100; and n is an integer from 1 to 10. wherein R* is a bond or OR', wherein R' is hydrogen, C 1-12 alkyl, substituted C 1-10 alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl or -(CH 2 -CH 2 -O)- m; R is hydrogen or a protection group; m is an integer from 1-100; and n is an integer from 1 to 10.
Composite for producing of an antiballistic article, the composite comprising at least two fabric layers, comprising high tensile strength fibers have a tensile strength of at least 1100 MPa according to ASTM D-885 and at least one layer of polyvinylbutyral between the at least two fabric layers, whereby the layer of polyvinylbutyral is a foil and exhibits a thickness between 30 and 70 μm.
Method of separating food products, with the following steps: - transporting the food product in the direction of transport with a conveying device (2, 2a, 2b), - cutting through the food product, wherein a cutting element is moved through the food product and moved along with the food product in the direction of transport, wherein - the motion of the cutting element is controlled into a first direction and, independent of this motion, into a second direction, - the food product does not rest on the conveying means (2, 2a, 2b) in the cutting area and. - during the separation operation, the cutting element is controlled such that it moves towards the food product and completely through the food product beyond the outer surface of the food product while it moves along with the food in the direction of transport. - transporting the food product in the direction of transport with a conveying device (2, 2a, 2b), - cutting through the food product, wherein a cutting element is moved through the food product and moved along with the food product in the direction of transport, wherein - the motion of the cutting element is controlled into a first direction and, independent of this motion, into a second direction, - the food product does not rest on the conveying means (2, 2a, 2b) in the cutting area and. - during the separation operation, the cutting element is controlled such that it moves towards the food product and completely through the food product beyond the outer surface of the food product while it moves along with the food in the direction of transport.